BNY Mellon Tax Managed Growth Fund NVO Holdings History
BNY Mellon Tax Managed Growth Fund's Novo Nordisk AS Holding Summary
As of 2025-01-31, BNY Mellon Investment Funds IV, Inc. held 50,040.00 shares of Novo Nordisk AS(NVO), totaling $4.23 Mil. This investment constitutes 3.16% of their stock portfolio, and BNY Mellon Investment Funds IV, Inc. now holds 0% of the outstanding Novo Nordisk AS(NVO) stock.
The initial trade took place in 2019Q4. In addition, there have been 13 sales at an average price of $97.67 for 25,120.00 shares. Based on historical transaction data and NVO's current price of $70.73, BNY Mellon Tax Managed Growth Fund's estimated gain on his NVO holdings is $4.05 Mil, reflecting a 208.32% gain to date.
BNY Mellon Tax Managed Growth Fund NVO ($70.73) Holding Chart
BNY Mellon Tax Managed Growth Fund NVO ($70.73) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
